Drug recall · July 1, 2026
Lacosamide Tablets recall
Why: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
- Lots / codes
Lot: A253999, A254000, Expires: 09/30/2027.
- Quantity
- 31,392 60-count bottles
- Company
- Annora Pharma Private Limited, Hyderabad, N/A
- Distribution
- Nationwide in the USA
- Initiated
- June 4, 2026 · Voluntary: Firm initiated
- Classified
- June 25, 2026
- Reported
- July 1, 2026
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lacosamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.